Granahan Investment Management’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
FLAM
NI
WCA
Granahan Investment Management's HCAT Position: Q1 2025 in Review
Granahan Investment Management sold out of Health Catalyst (HCAT) in Q1 2025, closing a stake of 493,364 shares — an estimated $3.49M sold.
Granahan Investment Management first reported a position in HCAT in Q3 2020 and held it in 18 quarters. The position peaked at $16.8M in Q4 2021. 165 funds tracked by Wall St. Rank hold HCAT as of Q1 2025.
- Granahan Investment Management reported no remaining Health Catalyst position as of Q1 2025 after selling out during the quarter.
- Granahan Investment Management sold 493,364 Health Catalyst shares in Q1 2025, an estimated $3.49M.
- Granahan Investment Management first reported a position in Health Catalyst in Q3 2020 and held it in 18 quarters.
- Granahan Investment Management's Health Catalyst position peaked at $16.8M in Q4 2021.
- 165 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2025.
Based on Granahan Investment Management's 13F filing for Q1 2025, filed 15 May 2025.